One of our clients was diagnosed with stage 4 neuroblastoma (cancer of nerve cells) when he was 10 months old. As part of his treatment, he received a transplant of his own cord blood. The transplanted stem cells successfully engrafted (the indicator of a transplant’s success) shortly after the transplant due to the quantity and superior quality of the banked cells. Over 3 years after the transplant the boy is healthy and is enjoying a normal childhood. His long-term survival demonstrates Progenics’ superior banking quality.
“We are so happy that we had made the choice of storing his cord blood at birth with Progenics though we never thought we would use it.”
- Adrian’s parents
